**Core Concept:** Tuberculous pericarditis is a subtype of tuberculosis (TB) infection involving the pericardium, which is the thin layer of connective tissue that surrounds the heart. The DOTS strategy refers to the Directly Observed Treatment, Short-course strategy developed by the World Health Organization (WHO) for treating Mycobacterium tuberculosis infections, including TB and Tuberculous pericarditis.

**Why the Correct Answer is Right:** Tuberculous pericarditis falls under Category B of the DOTS strategy, which is designed for treating both drug-sensitive and drug-resistant TB cases. These cases usually require a combination of four first-line anti-TB drugs (isoniazid, rifampicin, pyrazinamide, and streptomycin or ethambutol) for a minimum of 2 months, followed by a continuation phase with two drugs (isoniazid and rifampicin) for 4 months to 6 months, depending on the drug susceptibility test results.

**Why Each Wrong Option is Incorrect:**

A. Tuberculous pericarditis is not a Category A case, as it involves drug-sensitive TB cases.
B. Tuberculous pericarditis does not fall under Category C, which focuses on case finding and treatment of multidrug-resistant TB cases.
D. Tuberculous pericarditis is not related to Category E, which focuses on treatment of latent TB infection.

**Clinical Pearl:** Tuberculous pericarditis often presents with nonspecific symptoms, including chest pain, fever, and weight loss. These symptoms alone are not sufficient for diagnosing the disease, as they can be seen in other conditions as well. Diagnosing tuberculous pericarditis requires additional investigations such as Echocardiography, Chest X-ray, and Mantoux test or QuantiFERON-TB Gold test, which is more specific than the Mantoux test.

**Correct Answer:** Category B (Tuberculous pericarditis is a drug-sensitive TB case)